Hans Edgar Bishop

CIK 1480212 · CEO & President · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$82.08M

Companies

6

Total Filings

71

Lifetime Open-Market Net

-$34.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SANA Director 5,848,503 $2.68 $15.67M $0 26 2026-06-05
LYEL Director 4,685,614 $13.50 $63.26M $0 7 2024-06-17
A Director 24,226 $129.84 $3.15M $0 9 2024-03-19
CELGENE CORP /DE/ (CELGZ) Delisted Director 0 $0 3 2019-11-22
Juno Therapeutics, Inc. (JUNO) Delisted CEO & President 135,452 -$34.48M 17 2018-03-07
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Director 93,350 $0 3 2014-02-14

Recent Filings · Page 3 of 8

71 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-09 SANA Grant (A) $0 EDGAR
2023-04-06 SANA Grant (A) +7,716 $0 EDGAR
2023-03-20 A Grant (A) +2,399 $328.2K EDGAR
2023-01-06 SANA Grant (A) +6,702 $0 EDGAR
2022-10-06 SANA Grant (A) +4,012 $0 EDGAR
2022-09-09 LYEL Exer (M) +145,380 $14.5K EDGAR
2022-07-07 SANA Grant (A) +3,328 $0 EDGAR
2022-06-10 LYEL Grant (A) $0 EDGAR
2022-06-08 SANA Grant (A) $0 EDGAR
2022-04-06 SANA Grant (A) +2,880 $0 EDGAR
Showing 2130 of 71
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.